Linked Life Data

6193221

Source:http://linkedlifedata.com/resource/pubmed/id/6193221

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6193221rdf:typepubmed:Citationlld:pubmed
pubmed-article:6193221lifeskim:mentionsumls-concept:C0021013lld:lifeskim
pubmed-article:6193221lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:6193221lifeskim:mentionsumls-concept:C0870441lld:lifeskim
pubmed-article:6193221lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:6193221lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:6193221lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:6193221lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:6193221lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:6193221lifeskim:mentionsumls-concept:C0205345lld:lifeskim
pubmed-article:6193221lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:6193221lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:6193221lifeskim:mentionsumls-concept:C0205165lld:lifeskim
pubmed-article:6193221pubmed:issue2lld:pubmed
pubmed-article:6193221pubmed:dateCreated1983-10-8lld:pubmed
pubmed-article:6193221pubmed:abstractTextTwo different cross-reactive idiotype (CRI) groups are distinguishable in the Ab response of A/J mice to the p-azobenzenearsonate (ABA) hapten: CRIA and CRIm. These two groups showed distinct patterns of relative dominance in the ensuing response depending on whether the inducing Ag was a T cell-dependent (TD) form of ABA, such as ABA-KLH or ABA-CGG, or a T-independent type 1 (TI-1) form, such as ABA-Brucella abortus or ABA-lipopolysaccharide (LPS), and on whether the response was elicited in vivo or in vitro. The CRI+ component of primary in vivo plaque-forming cell (PFC) responses to TD ABA Ags was largely (greater than 90%) CRIA+ as was, to a slightly lesser extent (greater than 75%) the CRI+ portion of secondary or hyperimmune serum Ab or PFC responses to the same Ags. In contrast, in vivo primary and hyperimmune PFC responses to ABA-Bru or ABA-LPS showed a significantly lower CRIA/CRI ratio, averaging 0.5-0.6, with some individual mice giving figures as low as 0.2, indicating predominance of CRIm over CRIA. Serological analysis of hyperimmune anti-ABA Abs from a group of 5 A/J mice immunized with ABA-Bru gave a figure of less than 0.5 for the CRIA/CRI ratio. The most striking disparity from the TD pattern was seen in primary in vitro PFC responses to the TI ABA Ags; here ratios of less than 0.2 were generally seen. Since T cell removal did not alter the Id pattern in the TI responses, CRIA-specific Ts cells do not account for the weak expression of CRIA in such responses. We propose a model that explains these results on the basis of differential expression of IdX dominance by two distinct B cell subpopulations--equatable to the Lyb-5+ and Lyb-5- B cell subsets--along with differential relative activation of these subsets in different types of responses. Examination of anti-ABA PFC responses of F1 progeny of CBA/N and A/J mice to ABA-Bru lends support to this hypothesis since CRIA expression was significantly lower in mice with the xid defect.lld:pubmed
pubmed-article:6193221pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:languageenglld:pubmed
pubmed-article:6193221pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:citationSubsetIMlld:pubmed
pubmed-article:6193221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6193221pubmed:statusMEDLINElld:pubmed
pubmed-article:6193221pubmed:monthAuglld:pubmed
pubmed-article:6193221pubmed:issn0022-1007lld:pubmed
pubmed-article:6193221pubmed:authorpubmed-author:CongerJ DJDlld:pubmed
pubmed-article:6193221pubmed:authorpubmed-author:NisonoffAAlld:pubmed
pubmed-article:6193221pubmed:authorpubmed-author:LewisG KGKlld:pubmed
pubmed-article:6193221pubmed:authorpubmed-author:GoodmanJ WJWlld:pubmed
pubmed-article:6193221pubmed:authorpubmed-author:LamoyiEElld:pubmed
pubmed-article:6193221pubmed:issnTypePrintlld:pubmed
pubmed-article:6193221pubmed:day1lld:pubmed
pubmed-article:6193221pubmed:volume158lld:pubmed
pubmed-article:6193221pubmed:ownerNLMlld:pubmed
pubmed-article:6193221pubmed:authorsCompleteYlld:pubmed
pubmed-article:6193221pubmed:pagination438-51lld:pubmed
pubmed-article:6193221pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
pubmed-article:6193221pubmed:meshHeadingpubmed-meshheading:6193221-...lld:pubmed
More...